Last updated on February 2018

Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma


Brief description of study

Hepatocellular carcinoma is the third most common cause of cancer-related mortality. In recent years, transarterial chemoembolization, radio frequency ablation and microwave ablation have been accepted as treatment modalities for patients with surgically unresectable hepatocellular carcinoma.

Detailed Study Description

To compare between combination treatment with radiofrequency or microwave ablation followed by transarterial chemoembolization and performed in a single session.

Clinical Study Identifier: NCT02646137

Contact Investigators or Research Sites near you

Start Over

Sherief Abd-Elsalam

Tanta university hospital
Tanta, Egypt
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.